drugset

drugset / Trial / NCT04151212

A Phase I Clinical Trial of BAT5906 Injection in Patients With Wet Age-related Macular Degeneration

NCT04151212 ↗

Phase 1 Completed 24 enrolled Bio-Thera Solutions

NaSingle-groupOpen-labelTreatment

Summary

A Phase I Clinical Trial for BAT5906(single-dose;for injection) on Safety and Pharmacokinetics for Patients with Age-related macular degeneration.

Timeline

Start: 2018-10-30
Primary completion: 2021-02-28
Completion: 2021-04-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	BAT5906	Unknown	0.3 mg	Intravitreal

Indications